Caplin Point Laboratories Ltd 524742
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹1,920.50
- Day Range
- ₹1,905.35–1,924.95
- 52-Week Range
- ₹950.00–2,158.20
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹145.30 Bil
- Volume/Avg
- 7,894 / 21,489
Key Statistics
- Price/Earnings (Normalized)
- 30.79
- Price/Sales
- 8.42
- Dividend Yield (Trailing)
- 0.26%
- Dividend Yield (Forward)
- 0.26%
- Total Yield
- 0.26%
Company Profile
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 4,882
- Website
- https://www.caplinpoint.net
Comparables
Valuation
|
Metric
|
524742
|
544210
|
500288
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.79 | 49.71 | 37.41 |
Price/Book Value | 6.75 | — | 5.21 |
Price/Sales | 8.42 | 4.11 | 2.55 |
Price/Cash Flow | 32.06 | 32.30 | 34.57 |
Price/Earnings
524742
544210
500288
Financial Strength
|
Metric
|
524742
|
544210
|
500288
|
|---|---|---|---|
Quick Ratio | 4.35 | 0.75 | 0.87 |
Current Ratio | 5.71 | 1.33 | 2.21 |
Interest Coverage | 991.07 | 4.09 | 36.06 |
Quick Ratio
524742
544210
500288
Profitability
|
Metric
|
524742
|
544210
|
500288
|
|---|---|---|---|
Return on Assets (Normalized) | — | 8.13% | — |
Return on Equity (Normalized) | — | 21.12% | — |
Return on Invested Capital (Normalized) | — | 14.02% | — |
Return on Assets
524742
544210
500288
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Mqjgfjgbpc | Szjd | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Jqpqdhyff | Vtcff | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Hdzfzgxzm | Nrgs | $48.4 Bil | |||
| Viatris Inc
VTRS
| Srfphfwt | Fkfzy | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Fwbtjmrwl | Dfr | $13.5 Bil | |||
| Catalent Inc
CTLT
| Hnnmxllf | Hjspqc | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Pltbfnzk | Kftgzn | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Jqkdlrkj | Wlb | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Vwfyxtryq | Xcg | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Rmndjndq | Phwm | $2.3 Bil |
United States